Journal Article Summary
The article investigates the effectiveness of low-intensity extracorporeal shockwave therapy (Li-ESWT) as a treatment for erectile dysfunction (ED) in men who do not respond to phosphodiesterase inhibitors (PDE5is), which are commonly used medications for this condition. ED is a prevalent issue that can significantly impact men's quality of life, and finding effective non-invasive treatment options is crucial, especially for those who have not benefited from traditional medications. The study aims to share real-life experiences and outcomes from patients treated with Li-ESWT, highlighting its potential as an alternative therapy.
The research involved a retrospective analysis of 126 patients who underwent Li-ESWT after failing to respond to at least six trials of PDE5is. The treatment protocol lasted for 12 weeks, and the severity of ED was measured using the International Index of Erectile Function-5 (IIEF-5) score. Results showed a significant improvement in erectile function, with average IIEF scores increasing from 10.19 before treatment to 14.29 after three months of Li-ESWT. However, the effectiveness varied among patients, particularly those with severe ED and underlying conditions like diabetes, which appeared to limit the benefits of the therapy.
Despite the promising findings, the study has several limitations, including its retrospective design, small sample size, and lack of a control group, which may affect the reliability of the results. Patients should be aware that while Li-ESWT may help some individuals, those with severe ED or certain health conditions might not experience the same level of improvement. It is essential for patients to discuss their specific situation and treatment options with a healthcare professional to determine the best approach for managing their ED.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Bayraktar Necmi. Non-invasive alternative for phosphodiesterase inhibitor-refractory erectile dysfunction: Real-life experience with low-intensity extracorporeal shockwave therapy. Medicine 2023. DOI: 10.1097/MD.0000000000035939. PMID: 37960801. PMCID: PMC10637505.
Featured Pill Pals Product
Tadalafil 5 MG Tablets --- Generic for Cialis --- Ajanta Pharma
Tadalafil 5 MG Tablets — Generic for Cialis — Ajanta Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
